# Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH

> **NCT06074965** · NA · COMPLETED · sponsor: **Azienda Ospedaliera San Camillo Forlanini** · enrollment: 16 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Lipohypertrophy

## Interventions

- **DEVICE:** Medtronic Extended Infusion Set

## Key facts

- **NCT ID:** NCT06074965
- **Lead sponsor:** Azienda Ospedaliera San Camillo Forlanini
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-05
- **Primary completion:** 2023-05-23
- **Final completion:** 2023-05-23
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06074965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06074965, "Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06074965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*